CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,035,000 | -76.7% | 135,921 | -75.4% | 0.05% | -79.1% |
| Q1 2020 | $8,725,000 | -24.9% | 551,519 | -22.9% | 0.22% | -4.3% |
| Q4 2019 | $11,617,000 | +11.1% | 715,351 | +1.6% | 0.23% | -1.7% |
| Q3 2019 | $10,460,000 | -6.0% | 703,873 | +4.6% | 0.23% | -10.3% |
| Q2 2019 | $11,123,000 | -1.6% | 672,885 | +2.9% | 0.26% | -1.9% |
| Q1 2019 | $11,309,000 | – | 653,715 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|